Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury

Stroke

Volumn 41, Issue 5, 2010, Pages 1032-1037

  Iwai, Masanori ^a,c   Stetler, R Anne ^a,b,c   Xing, Juan ^c   Hu, Xiaoming ^c   Gao, Yanqin ^b   Zhang, Wenting ^b   Chen, Jun ^a,b,c   Cao, Guodong ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Erythropoietin; Neonatal hypoxia ischemia; Neurogenesis; Oligodendrogenesis; White matter injury

Indexed keywords

BROXURIDINE; ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; CELL MATURATION; CELL MIGRATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG ACTIVITY; IMMUNOHISTOCHEMISTRY; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGENESIS; OUTCOME ASSESSMENT; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; WHITE MATTER INJURY;

ANIMALS; ANIMALS, NEWBORN; ERYTHROPOIETIN; HYPOXIA-ISCHEMIA, BRAIN; NEUROGENESIS; NEURONS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

EID: 77951766719     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.570325     Document Type: Article

References (18)

1. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641-1647. (Pubitemid 26295918)
2. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002;22:455-463. (Pubitemid 34049083)
3. Mandai K, Matsumoto M, Kitagawa K, Matsushita K, Ohtsuki T, Mabuchi T, Colman DR, Kamada T, Yanagihara T. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience. 1997;77:849-861. (Pubitemid 27100579)
4. Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neuro-genesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38: 2795-2803. (Pubitemid 47494020)
5. van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev. 2008;59:22-33.
6. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495-505. (Pubitemid 36337492)
7. Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q, Panda S, Kapke A, Lu M, Ewing JR, Chopp M. MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke. 2009;40:936-941.
8. Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol. 1997;41:521-529. (Pubitemid 27169192)
9. Liu Y, Silverstein FS, Skoff R, Barks JD. Hypoxic-ischemic oligoden-droglial injury in neonatal rat brain. Pediatr Res. 2002;51:25-33. (Pubitemid 34008206)
10. McTigue DM, Tripathi RB. The life, death, and replacement of oligo-dendrocytes in the adult CNS. J Neurochem. 2008;107:1-19.
11. Chikuma M, Masuda S, Kobayashi T, Nagao M, Sasaki R. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab. 2000;279:E1242-E1248.
12. Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 2001;101:271-276. (Pubitemid 32219761)
13. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21:9733-9743. (Pubitemid 34184059)
14. Andrews RJ. Transhemispheric diaschisis. A review and comment. Stroke. 1991;22:943-949.
15. Genc K, Genc S, Baskin H, Semin I. Erythropoietin decreases cyto-toxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol Res. 2006;55:33-38. (Pubitemid 43276809)
16. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44:391-403. (Pubitemid 35341813)
17. van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F. Combination of deferoxamine and erythropoietin: Therapy for hypoxia-ischemia- induced brain injury in the neonatal rat? Neurosci Lett. 2009; 451:109-113.
18. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke. 2004;35:1732-1737. (Pubitemid 38823656)